Chemcrux Enterprises Ltd. engages in the manufacture of intermediates for bulk drugs, dyes, electro-plating, pharmaceuticals, and pigments. The company is headquartered in Ankleshwar, Gujarat. The company went IPO on 2017-03-28. The firm is engaged in manufacturing intermediates for bulk drugs, and dyes and pigments. The firm's products include 2 Chloro Benzoic Acid, 3 Chloro Benzoic Acid, 4 Chloro Benzoic Acid, 2,4 Dichloro Benzoic Acid, 4 Chloro 3 Nitro Benzoic Acid; 2 Chloro 5 Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lassamide, and Meta Chloro Per Benzoic Acid. The firm also offers various products on custom requirements, including Aceturic Acid; Meta Chloro Benzoyl Chloride; 3-Nitro-4-Methoxy Benzoic Acid; 2 Amino 5 Sulfonamide Benzoic Acid; 3,4 Dichloro Benzoic Acid; 5-Nitro Salycylic Acid, and 4-Chloro Benzoic Acid -3-Sulfonamide. The company is engaged in development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation and Chloro Sulfonation.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
14 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.